LifeCodexx to Develop Sequencing-Based Preeclampsia Test; Considers PacBio RS as Assay Platform

LifeCodexx parent company GATC Biotech has ordered a PacBio RS instrument, which the companies plan to investigate for use in their test protocol.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.